Viemed Healthcare US ( (VMD) ) has released its Q3 earnings. Here is a breakdown of the information Viemed Healthcare US presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Viemed Healthcare, Inc. is a U.S.-based in-home clinical care provider specializing in post-acute respiratory healthcare equipment and services, including non-invasive ventilators and sleep therapy. The company focuses on delivering effective in-home treatment through a combination of clinical expertise and advanced technology.
Viemed Healthcare has reported a record-breaking third quarter for 2025, with net revenues reaching $71.9 million, marking a 24% increase from the same period last year. The company attributes this growth to strategic acquisitions and an expanding patient base across its major service lines.
Key financial highlights include a net income of $3.5 million and an adjusted EBITDA of $16.1 million, reflecting a 15.5% increase year-over-year. The acquisition of Lehan’s Medical Equipment has been immediately accretive to earnings, and the company has successfully repurchased over 1.7 million shares, enhancing shareholder value. Viemed also reported strong cash flow, with $18.4 million generated from operating activities in the quarter.
Looking ahead, Viemed has updated its full-year 2025 guidance, projecting net revenues between $271 million and $273 million, and adjusted EBITDA between $60 million and $62 million. The company remains focused on strategic growth opportunities and maintaining financial strength to support long-term success.